# Relationship Between Morning Blood Pressure Surges and Peripheral Inflammatory Biomarkers in Parkinson’s Disease

**Authors:** Ummu S. Sari, Seda E. Yildirim, Gulseren Buyukserbetci, Tarik Yildirim, Mesut Sackes, Figen Esmeli

PMC · DOI: 10.3390/biomedicines13020363 · Biomedicines · 2025-02-05

## TL;DR

This study explores how morning blood pressure surges relate to inflammation in Parkinson’s disease patients.

## Contribution

The study is the first to link morning blood pressure surges with inflammatory biomarkers in Parkinson’s disease patients.

## Key findings

- Morning blood pressure surges were significantly higher in Parkinson’s disease patients compared to controls.
- The study suggests that these surges may reflect autonomic dysfunction and could contribute to cardiovascular risks in PD patients.

## Abstract

Background: Parkinson’s disease (PD) is the second-most prevalent neurodegenerative disorder, often resulting in blood pressure abnormalities due to autonomic dysfunction. The early morning rise in blood pressure, referred to as the morning surge, has been associated with various cardiovascular diseases when exaggerated. This study aims to investigate the relationship between morning blood pressure surge (MBPS) and inflammatory markers in patients with PD. Methods: In this retrospective study, we employed 24 h ambulatory blood pressure monitoring alongside the fibrinogen-to-albumin ratio and high-sensitivity C-reactive protein (hs-CRP) as inflammatory markers. The study included fifty idiopathic PD patients and fifty age- and sex-matched control subjects. MBPS was defined as the difference between morning blood pressure (measured two hours after awakening) and the lowest recorded nighttime blood pressure. Body mass index (BMI) was considered as an independent variable. Results: Our study found that morning blood pressure surge (MBPS) levels were significantly higher in Parkinson’s disease (PD) patients compared to the control group, suggesting possible autonomic involvement. Conclusions: MBPS may indicate autonomic involvement, potentially contributing to cardiovascular and cerebral morbidity and mortality in PD patients. Longitudinal studies with larger sample sizes are warranted to further elucidate this relationship.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** PD (MESH:D010300), Inflammatory (MESH:D007249), autonomic dysfunction (MESH:D001342), Blood Pressure (MESH:D006973), cardiovascular diseases (MESH:D002318), neurodegenerative disorder (MESH:D019636)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11853463/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11853463/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC11853463/full.md

---
Source: https://tomesphere.com/paper/PMC11853463